Aug 31, 2026 · 32 min
Pediatric cancer care expands beyond survival
Ep. 211: Changing What’s Possible for Children With Cancer
The episode connects one teenager’s difficult recovery with efforts to make pediatric cancer treatment more targeted, supportive, and responsive to patients’ lives.
- 1Olivia Eder’s treatment moved from prolonged chemotherapy to an intensive bone marrow transplant after a life-threatening diagnosis.
- 2Adolescent and young adult oncology services aim to address patients’ medical and developmental needs between pediatric and adult care.
- 3Clinical trials, circulating tumor DNA, and artificial intelligence are reshaping how researchers study and treat childhood cancer.
Don't miss
Olivia explains how her expected two-and-a-half-year chemotherapy plan changed to an intensive bone marrow transplant, with her father serving as donor.
The brief
Olivia Eder recounts how breathing problems led to a diagnosis of T-cell lymphoblastic lymphoma, followed by urgent treatment for an airway-threatening tumor.
Chemotherapy disrupted school, friendships, sports, and ordinary teenage milestones. When her treatment plan changed, a bone marrow transplant using her father as donor shortened the expected course but intensified recovery.
Olivia’s return to everyday life—including school, theater, sports, and a Phillies Childhood Cancer Awareness Day—underscores that young patients remain more than their diagnoses.
Douglas J. Harrison describes Nemours Children’s Health’s adolescent and young adult oncology services and a brighter outpatient center designed around patients, families, and staff.
The research agenda reaches from national clinical trials and circulating tumor DNA to artificial intelligence that could reveal molecular pathways and tumor biology more clearly.